Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
REPL | Replimune Group, Inc. | Chief Dev. Op. Officer | $1.48M | Jun 13, 2023 | ||
DMAC | DiaMedica Therapeutics Inc. | Director | $0 | Jun 1, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|